Skip to main content
. 2015 Jan 24;17(6):801–809. doi: 10.1093/neuonc/nou363

Fig. 5.

Fig. 5.

(A) mRNA expression analysis of FoxP3 and (B) Helios in tumors of patients with different subtypes of glioblastoma. Multiple-comparison 1-way ANOVA indicated significant difference in the expression of Treg markers between the classical group and other subtypes. (C) Glioblastoma patients with low FoxP3 mRNA or (D) low FoxP3 and Helios mRNA were analyzed for OS. The cohort analyzed included 54 classical, 56 proneural, 56 mesenchymal, and 29 neural glioblastoma cases. No difference was found between groups for either FoxP3 (P = .812) or FoxP3 and Helios combined (P = .816).